Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 4-Quinolinamine, N-5-benzothiazolyl-6-[(1-methylethyl)sulfonyl]- | 1346546-69-7 | 99.9% | 383.49 | 50 MG
SDP

Supplier:  Medchemexpress LLC 50MGHY101872

Encompass_Preferred

GSK-872 is a potent RIPK3 inhibitor that binds to the RIP3 kinase domain with an IC50 of 1.8 nM and inhibits kinase activity with an IC50 of 1.3 nM. It effectively decreases RIPK3-mediated necroptosis, subsequent cytoplasmic translocation, and expression of HMGB1. This compound also demonstrates the ability to ameliorate brain edema and neurological deficits in early brain injury models.

  • Targets RIPK3.
  • Binds RIP3 kinase domain with an IC50 of 1.8 nM.
  • Inhibits kinase activity with an IC50 of 1.3 nM.
  • Decreases RIPK3-mediated necroptosis.
  • Reduces cytoplasmic translocation and expression of HMGB1.
  • Ameliorates brain edema and neurological deficits in early brain injury.
  • For research use only.

Catalog No. 50-003-65942


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.